. Structures of GSAO and GSAA monothiols. PAO is lipophilic and is generally toxic for all cul-GSAO-mediated swelling of mitochondria decreased with increasing Ca 2ϩ concentration ( Figure 2B ). tured cells after exposure to nanomolar concentrations for 1 day (unpublished observations). We made a hydrophilic derivative of PAO by attaching it to the cysteine thiol of reduced glutathione GSAO interacted directly with ANT Considering that GSAO has the same dithiol reactivity as PAO, (GlyCys␥Glu) to produce 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) (Donoghue et al., 2000) (Figure 1 ). We it was expected to mimic PAO's binding to ANT. Direct interaction of ANT with a biotin-tagged describe the induction of mitochondrial permeability by GSAO. The compound was toxic to proliferating, but not growthtinoyl)amino)hexanoyl)amino)hexanoyl)-glutathionyl)acetyl)amino) phenylarsenoxide, GSAO-B) is shown in Figures 2C and 2D . quiescent, endothelial cells in vitro and an inhibitor of angiogenesis in vivo.
Isolated mitochondria were incubated with 10 M biotintagged GSAO (GSAO-B) or GSAA (GSAA-B), the labeled proteins were collected on avidin-coated beads, and the specifically Results bound proteins were eluted from the beads with an excess of the small synthetic dithiol, dithiothreitol. From comparison with GSAO induced the mitochondrial permeability transition GSAO triggered swelling of isolated rat liver mitochondria in a the control experiment using GSAA-B, four GSAO-interacting proteins were clearly identified ( Figure 2C ). These proteins have time-and concentration-dependent manner (Figure 2Ai ). The trivalent arsenical moiety of GSAO was responsible for this activmolecular masses of ‫,06ف‬ 32, 30, and 19 kDa. The 30 kDa protein corresponded to ANT by Western blot ( Figure 2D ). Eoity as the corresponding pentavalent arsenical (4-(N-((S-glutathionyl)acetyl)amino)benzenearsonic acid, GSAA) ( Figure 1 ) had sine-maleimide alkylates Cys 160 in ANT and blocks ADP binding (Halestrap et al., 1997; Majima et al., 1998; . . cyclophilin D, and adenine nucleotides under physiological conditions. The primary trigger for opening of the MPTP is a rise in GSAO localized to endothelial cell mitochondria A striking feature of GSAO was that it rapidly localized to mitomatrix Ca 2ϩ concentration. Chelation of Ca 2ϩ with EGTA blocks pore opening, as does an excess of other divalent metal ions chondria in viable bovine aortic (BAE) ( Figure 3 ) and human dermal microvascular (HMEC-1) (data not shown) endothelial such as Mg 2ϩ (Haworth and Hunter, 1979; Hunter and Haworth, 1979; Bernardi et al., 1992) . Both EGTA and Mg 2ϩ blocked cells. GSAO was conjugated to fluorescein (GSAO-F) and its subcellular localization was determined by confocal fluores-GSAO-dependent swelling (Figure 2Aiii ). Binding of cyclophilin D to ANT is necessary for pore opening at submillimolar Ca 2ϩ cence microscopy. Mitochondrial staining was confirmed by colocalization of GSAO-F with the red-fluorescent Mitotracker concentrations. Cyclosporin A (CsA) blocks pore opening by binding to cyclophilin D and displacing it from ANT (Crompton probe, which accumulates in the mitochondria of actively respiring cells (Figure 3ii , 3iv, and 3vi) (Poot et al., 1996) . The mitoet al., 1988; Halestrap et al., 2002) . In addition, ADP and bonkrekic acid (BKA) inhibit pore opening by binding to ANT and chondrial accumulation of GSAO-F was specific for the dithiol reactivity of GSAO as it was abolished in the presence of a decreasing the sensitivity of the trigger site to Ca 2ϩ Hunter, 1979, 2000; Hunter and Haworth, 1979 ; LeQuoc 5-fold molar excess of dimercaptopropanol (Figure 3iii ), and the corresponding pentavalent arsenical GSAA-F did not stain the and LeQuoc, 1988; Halestrap et al., 1997) . CsA, ADP, and BKA all blocked the effect of GSAO on pore opening (Figure 2Aiii ). cells ( Figure 3v ). Endothelial cells were incubated with 3 M tritiated GSAO There is one cysteine in each of the three loops of ANT that protrude into the matrix, Cys . The oxidaet al., 2002) . The two effects together greatly sensitize the trigger site to Ca 2ϩ concentration, which facilitates pore opening. In tion state of the arsenical moiety, therefore, had little effect on the rate of entry of the compound into endothelial cells. This accordance with this mechanism, the time for half-maximal concentrations and the time for half-maximal swelling was measured. C: Mitochondria were incubated with 10 M biotin-tagged GSAO or GSAA, the labeled proteins were collected on avidin-coated beads, and the specifically bound proteins were eluted from the beads with an excess of dithiothreitol. From comparison with the control experiment using GSAA-biotin (lane 2), four GSAO interacting proteins were identified with molecular masses of ‫,06ف‬ 32, 30, and 19 kDa (lane 1). D: Western blot for ANT on mitochondrial proteins that bound to GSAO-B in the absence (lane 1) or presence (lane 2) of a 5-fold molar excess of 2,3-dimercaptopropanol (DMP). E: SDS-PAGE of eosin-5-maleimide labeled ANT in the absence (lane 1) or presence (lane 2) of GSAO.
finding indicated that GSAA is a valid control compound for the induced mitochondrial swelling. The Ca 2ϩ content of BAE cells incubated with 10% (proliferating) or 0.25% (growth-quiescent) intracellular effects of GSAO.
serum and the effect of GSAO on the viability of these cells were measured.
GSAO triggered mitochondrial depolarization and apoptosis in proliferating, but not
Relative cellular Ca 2ϩ concentrations were calculated with the ratiometric Ca 2ϩ indicator dye Indo-1 and flow cytometry.
growth-quiescent, endothelial cells
The finding that GSAO concentrated in the mitochondria of The fluorescence ratio for Ca 2ϩ bound to unbound Indo-1 was 48% higher in cells cultured for 48 hr in 10% serum compared viable cells suggested that it might perturb mitochondrial function and cell viability. Mitochondrial Ca 2ϩ uptake has been to 0.25% serum and 22% higher in cells cultured for 24 hr. The Ca 2ϩ content of proliferating endothelial cells was, therefore, shown to occur concurrently with increases in cytosolic Ca 2ϩ in response to physiological stimulants such as growth factors significantly higher than in quiescent cells. BAE cells were incubated for 48 hr in the presence of GSAO, and G protein-coupled receptor agonists that are present in serum (Hoek et al., 1995; Crompton, 1999; Rizzuto et al., 2000) . and the number of cells remaining attached at the end of the treatment was measured. The IC 50 for reduction in viability of We anticipated, therefore, that proliferating (serum-stimulated) cells would be sensitized to GSAO-mediated MPTP opening proliferating BAE cells after 48 hr exposure to GSAO was ‫57ف‬ M (Figure 4Ai ), whereas the compound had little effect on compared to growth-quiescent (nonstimulated) cells because of the sharp dependence on Ca 2ϩ for GSAO's effects on mitogrowth-quiescent cells. The same results were observed with HMEC-1 cells (data not shown). GSAA had no significant effect chondrial function (see Figure 2B ). This would result in the selective induction of apoptosis in proliferating, but not growth-quieson cell number at concentrations up to 1.0 mM (data not shown). The effect of GSAO on proliferating cell viability was time depencent, cells. This theory was supported by the findings of Hoek et al. (1995) , who observed that elevation of cytosolic Ca 2ϩ leads dent and a function of the cell density. The IC 50 for GSAO decreased from ‫57ف‬ M to ‫52ف‬ M when the incubation time to Ca 2ϩ accumulation in mitochondria and an increase in PAO-GSAO concentration, indicating induction of apoptosis by GSAO.
GSAO inhibited ATP production and increased superoxide levels in proliferating, but not growth-quiescent, endothelial cells The binding of GSAO to ANT and induction of apoptosis was expected to affect cellular ATP levels. The ATP content of proliferating BAE cells was approximately twice that of growth-quiescent cells, and incubation with 150 M GSAO for 24 hr reduced ATP levels in proliferating cells by 30% (Figure 5Ai ). To confirm that the decreased cellular ATP was due to an effect of GSAO on mitochondrial ATP synthesis rather than mitochondrial biogenesis, we measured mitochondrial mass using nonyl acridine orange. This dye binds to cardiolipin in the mitochondrial membrane (Petit et al., 1992) . The mitochondrial mass of proliferating cells was approximately twice that of growth-quiescent cells and was unchanged by GSAO treatment (Figure 5Aii ). Reactive oxygen species, such as superoxide anion (O 2 Ϫ ) and hydrogen peroxide (H 2 O 2 ), are generated as a byproduct of respiration and play an important role as signaling intermediates in cellular proliferation, but at elevated concentrations, they arrest proliferation and induce apoptosis by damaging many cellular components (Raha and Robinson, 2000; Zanetti et al., 2001) . One to two percent of oxygen consumed by mitochondrial respiration forms O 2 Ϫ through leakage of respiratory chain electrons directly to O 2 (Boveris et al., 1972; Turrens and Boveris, 1980) . This leakage can derive from the NADH dehydrogenase (complex I), the succinate quinone dehydrogenase (complex II), or the cytochrome b-c1 reductase (complex III) of the respiratory chain (Papa, 1996; Turrens and Boveris, 1980; Raha and Robinson, 2000) . Elevated O 2 Ϫ is also an indicator of mitochondrial damage or dysfunction (Fantin et al., 2002; Hiura et al., 2000) . solic Cu/Zn SOD (Vanden Hoek et al., 1998) . BAE cells were treated for 24 hr with GSAO, and the cellular levels of O 2 Ϫ and H 2 O 2 were measured using the dyes dihydroethidium and CM-H 2 -DCFDA, respectively. Cellular levels of O 2 Ϫ increased from 48 hr to 72 hr. The IC 50 also decreased with increased linearly with GSAO concentration in proliferating, but decreasing cell density. PAO, in contrast, was equally toxic to not growth-quiescent, BAE cells ( Figure 5B ). Simultaneous analboth proliferating and growth-quiescent BAE cells with an IC 50 ysis of cellular O 2 Ϫ and H 2 O 2 levels using two channel flow of ‫2.0ف‬ M (Figure 4Aii ). cytometry indicated that this effect of GSAO was not due to an Interestingly, there was a biphasic effect of PAO on endotheinhibition of SOD activity. O 2 Ϫ levels were increased in the majorlial cell viability. Low concentrations of PAO, but not GSAO, ity of cells without a corresponding decrease in H 2 O 2 (Figure stimulated endothelial cell proliferation. Inorganic arsenic (arse-5C). There was no effect of GSAA on O 2 Ϫ or H 2 O 2 levels (data not nic trioxide) also has this effect on cell proliferation (Barchowsky shown) . The linear increase in O 2 Ϫ levels with GSAO treatment et al., 1999) . The glutathione pendant of GSAO, therefore, has is consistent with a disruption of mitochondrial integrity. The changed the properties of the trivalent arsenical.
elevated O 2 Ϫ likely contributes directly to the proliferation arrest GSAO treatment induced caspase-3/7 activation (Figure and induction of apoptosis. 4B), loss of mitochondrial transmembrane potential, and surface presentation of phosphatidylserine ( Figure 4C ) in BAE cells.
GSAO was selectively toxic towards endothelial cells Mitochondrial transmembrane potential and phosphatidylserine compared to tumor cells exposure were measured using the JC-1 dye and FITC-conjuTo distinguish between the antiproliferative and proapoptotic gated annexin V, respectively. The ratio of distribution of JC-1 effects of GSAO, treated cells were stained with propidium iobetween the cytosol (green fluorescence) and mitochondria (red dide (PI) to detect late-apoptotic or dead cells. The total number fluorescence) reflects mitochondrial transmembrane potential of cells and the proportion of cells that were PI positive following (Smiley et al., 1991) . Caspase activation was commensurate 48 hr treatment with GSAO were measured by flow cytometry. with disruption of mitochondrial potential and exposure of phos-
The IC 50 for proliferation arrest of BAE ( Figure 6A ) or primary human dermal microvascular endothelial ( Figure 6B ) cells was phatidylserine. All three parameters increased with increasing ‫01ف‬ M and ‫51ف‬ M, respectively. The IC 50 for loss of viability (Nguyen et al., 1994) . GSAO inhibited CAM angiogenesis ( Figure  7A ) in a concentration-dependent manner ( Figure 7B ). GSAA was ‫57ف‬ M and ‫53ف‬ M, respectively, indicating that GSAO arrested proliferation at lower concentrations than were necesup to 50 g per pellet had no effect on CAM angiogenesis. GSAO induces proliferation arrest in endothelial cells at 2.3-sary to induce apoptosis. The IC 50 for proliferation arrest of bovine vascular smooth muscle cells was ‫03ف‬ M. In contrast, to 7.5-fold lower concentrations than are required to trigger apoptosis (see Figures 5A and 5B and Table 1 ). In the CAM all tumor cells tested were more resistant to GSAO ( Figures  6C-6G ). The concentrations of GSAO that induce proliferation assay, therefore, new blood vessels would not be expected to sprout from existing vessels in the vicinity of the GSAO pellet, arrest and loss of viability are 3-to Ͼ32-fold and 2-to 9-fold higher, respectively, for tumor cells than for endothelial cells which is what was observed. We next tested whether GSAO would inhibit tumor angiogenesis and tumor growth in mice. (Table 1) . GSAO treatment caused Lewis lung carcinoma cells to disaggregate, which was the reason for the apparent increase in cell number for this tumor line ( Figure 6E ).
GSAO inhibited tumor angiogenesis and tumor growth
Mice were administered GSAO by subcutaneous injection, and the plasma concentration of arsenic was measured by induc-GSAO inhibited CAM angiogenesis The ability of GSAO to selectively kill proliferating, but not tively coupled plasma mass spectrometry. This should reflect GSAO levels, as the concentration of arsenic in the plasma of growth-quiescent, endothelial cells in vitro suggested that it might be an effective inhibitor of angiogenesis in vivo. The untreated mice was below the level of detection. Subcutaneous administration of 10 mg/kg GSAO resulted in a plasma arsenic sprouting of new capillaries from existing vessels is termed angiogenesis and is driven by proliferating endothelial cells (Carconcentration of 6.4 Ϯ 0.9 M (n ϭ 5) after 30 min, which is in the range of the IC 50 for proliferation arrest of endothelial cells meliet and Jain, 2000) . In the normal adult mammal, angiogenesis is confined to the female reproductive cycle, wound healing, by GSAO in culture (Table 1) . Plasma arsenic peaked at Յ30 min and returned to baseline after ‫8ف‬ hr ( Figure 7C ). and diseases such as rheumatoid arthritis, psoriasis, diabetic retinopathy, and cancer. Tumor expansion and metastasis is
The growth of established human and murine primary tumors in immunocompromised and immunocompetent mice, redependent on tumor angiogenesis (Hanahan and Folkman, 1996) . spectively, was suppressed by administration of GSAO. Treatment of SCID mice bearing ‫1.0ف‬ g BxPC-3 ( Figure 7D ) or The chick chorioallantoic membrane (CAM) assay has been used for the detection and analysis of angiogenesis inhibition HT1080 ( Figure 7E ) tumors, or C57Bl6/J mice bearing ‫1.0ف‬ g LLC tumors (Figure 7F ), by subcutaneous administration of 10 at Ͼ30-fold higher concentrations (Table 1) , and systemic administration of GSAO markedly reduced tumor vascularity in mg/kg/day GSAO at a site remote from the tumor resulted in Ͼ90%, ‫,%07ف‬ and ‫%54ف‬ inhibition of the rate of tumor growth, vivo but had no effect on the proliferative index of the BxPC-3 tumor cells ( Figure 7H ). There was a significant increase in aporespectively. Administration of control GSAA caused Ͻ20% inhibition of the rate of tumor growth in all experiments when ptosis of the BxPC-3 tumor cells, which is in accordance with inhibition of tumor angiogenesis . The high compared to administration of vehicle alone (data not shown). This small inhibition of tumor growth by GSAA was perhaps rate of apoptosis balances the high proliferative rate of the tumor cells, resulting in no net gain in tumor size (Holmgren et al., due to enzymatic reduction of the compound to GSAO, possibly by a liver arsenate reductase (Radabaugh and Aposhian, 2000) . 1995). There were no apparent adverse affects of administration of either GSAO or GSAA to either SCID or C57Bl6/J mice. The Discussion average mice weights of the GSAO and GSAA treatment groups over the course of the experiments were not significantly differ-GSAO localized to endothelial cell mitochondria and induced Ca 2ϩ -dependent opening of the MPTP in isolated mitochondria, ent (data not shown), and there were no macroscopic differences or morphological changes apparent in the heart, lungs, directly crosslinking two cysteine residues on the matrix side of ANT. Perturbation of mitochondrial function in cultured endoliver, kidneys, and spleen of GSAO-or GSAA-treated mice.
Immunohistochemical analysis of the tumors from the experthelial cells was evidenced as an increase in the cellular levels of O 2 Ϫ at subapoptotic concentrations of GSAO, and a decrease iment described in Figure 7D indicated a significant reduction in blood vessel density in the GSAO-treated tumors (p Ͻ 0.001) in cellular ATP and loss of mitochondrial transmembrane potential at higher GSAO concentrations. High levels of reactive oxy-( Figures 7G and 7H) . The proliferative indices of the GSAAand GSAO-treated tumors were the same, while there was a gen species can arrest proliferation and induce apoptosis by damaging lipids, proteins, DNA, and RNA (Raha and Robinson, significant increase in the apoptotic indices of GSAO-versus GSAA-treated tumors (p ϭ 0.05) ( Figure 7H ).
2000; Davis et al., 2001; Zanetti et al., 2001) . In contrast, GSAO had little effect on mitochondrial function and viability of growthThe effect of GSAO on tumor growth is consistent with inhibition of tumor angiogenesis. GSAO arrested proliferation of quiescent endothelial cells. Although we cannot exclude an effect of GSAO on the activendothelial cells in vivo but had no effect on BxPC-3 proliferation ity of other mitochondrial proteins, the mitochondrial swelling
The strong selectivity of GSAO for proliferating cells was probably a consequence of two related events: the greater proand cell-based assays point to ANT as the relevant target in terms of the consequences for endothelial cell proliferation and pensity for MPTP opening due to higher mitochondrial Ca 2ϩ levels and the higher respiration rate in proliferating cells. The viability. ANT is the most abundant protein of the inner mitochondrial membrane (Klingenberg and Nelson, 1994) , and it elevated cellular levels of O 2 Ϫ most likely resulted from uncontrolled production and/or release from mitochondria following has been well established that disruption of ANT has major consequences for mitochondrial integrity and cell survival (Haleopening of the MPTP by GSAO. GSAO treatment did not increase cellular H 2 O 2 levels, which implied that it did not affect strap et al., 2002) . Proving that ANT is the most relevant target for GSAO in endothelial cells using genetic approaches is probthe thioredoxin and glutathione thiol buffering systems (Davis et al., 2001; Gladyshev et al., 2001; Chen et al., 2002) . Depleting lematic. Overexpression of ANT in mammalian cells induces apoptosis (Bauer et al., 1999) in a manner that may be unrelated the cellular thiol buffering capacity would be expected to result in elevated H 2 O 2 levels (Powis and Montfort, 2001) . to formation of the MPTP . GSAO's accumulation in the mitochondria of viable endoimmediate-early genes (Battini et al., 1987) . However, it seems unlikely that isoform specificity accounts for the selectivity of thelial cells was potentially driven by its interaction with ANT, which is abundant in the inner mitochondrial membrane. Se-GSAO for proliferating cells, since the three isoforms share Ͼ95% sequence similarity and the two cysteines that react with GSAO, questration of GSAO by mitochondrial dithiols, such as those in ANT, would drive further entropic import of GSAO into the Cys 160 and Cys
257
, are conserved in all three. Furthermore, we have observed no obvious difference in GSAO's mitochondrial matrix. This mechanism is supported by the finding that GSAA, which has effectively the same charge and size as GSAO, did localisation in proliferating versus growth-quiescent endothelial cells by confocal microscopy or sub-cellular fractionation (data not accumulate in mitochondria. Similarly, retention of the Mitotracker CMXRos dye is thought to be due to its reaction with not shown).
The mechanism of the selectivity of GSAO for endothelial mitochondrial protein thiols via its chloromethyl moiety (Poot et al., 1996) . versus tumor cells is under investigation. Preliminary findings suggest that the selectivity may relate to the capacity of the Three isoforms of ANT have been described in mammalian cells, which are differentially expressed in various human tissues cell to buffer GSAO's arsenical moiety. A major buffer appears to be reduced glutathione, as both endothelial and tumor cells (Ku et al., 1990; Doerner et al., 1997) . The ANT2 isoform is selectively expressed in proliferating cells together with the are more susceptible to GSAO when pre-treated with the gluta- aerobic glycolytic capacity (Pedersen, 1978; Papa, 1996) . thiols with the hydrophilic thiol-alkylating agents 5,5Ј-dithiobis(2-nitrobenzoic acid) or 3-(N-maleimidylpropionyl)biocytin Synthesis of GSAO BRAA was prepared as described above and was then converted to 4-(Nhad no effect on the anti-endothelial cell activity of GSAO, indi-(bromoacetyl)amino)benzenearsonous acid (BRAO) using the method decating that GSAO's effects were not due to perturbation of scribed in Donoghue et al. (2000) . The procedure for the conversion of BRAO a cell surface protein. Certain protein tyrosine phosphatases to GSAO is a modification of that described in Donoghue et al. (2000) , as (PTPases) are inactivated by trivalent arsenicals, due to the follows. Reduced glutathione (16 g, 52 mmol) was dissolved in deoxygenated presence of two unpaired cysteines in the active site (one of water (1 liter) under a nitrogen atmosphere (deoxygenated water was prethem is the catalytic cysteine) that form cyclic dithioarsinites pared by boiling followed by cooling to room temperature, all the time under with trivalent arsenicals (Liao et al., 1991; Defilippi et al., 1995;  an atmosphere of nitrogen). BRAO (25 g, 77 mmol) was suspended in the solution, and vigorous stirring of the mixture was applied until the undis- Yuan et al., 1998) . Incubation of endothelial cells with high misolved BRAO had lost all tendency to float, at which point the rate of stirring cromolar concentrations of GSAO resulted in increased tyrosine was decreased. Triethylamine (16 ml, 11.6 g, 115 mmol) was added, and phosphorylation of two proteins (focal adhesion kinase and paxthe mixture was stirred for at least 18 hr, all the time under nitrogen. Some illin), and GSAO was found to inhibit two PTPases (PTP-PEST colorless solid was removed by rapid vacuum filtration, and the filtrate was and PTP-1B). Overexpression of PTP-PEST or PTP-1B in endoconcentrated to a viscous gel on a rotary evaporator. The gel was diluted thelial cells did not blunt GSAO's effects on viability, however, with ethanol (250 ml), the rate of stirring was increased, and then acetone which implied that these PTPases were not GSAO's primary and confines its distribution mostly to the intravascular compartMHz), HPLC, and infrared spectroscopy (nujol mull). The elemental analysis ment. Preliminary studies in mice have shown that GSAO is was consistent with a composition of GSAO.2H 2 O, and the mass spectrum rapidly excreted in the urine within 30 min of intravenous admingave the parent molecular ion at 549.1 min·u· [GSAOϩH] ϩ . The purity of istration and does not appear to accumulate in any organs.
GSAO was Ͼ94% by HPLC.
Our findings indicate that hydrophilic dithiol-reactive compounds like GSAO appear to be an effective means of inhibiting Synthesis of biotin and fluorescein derivatives of GSAO and GSAA endothelial cell proliferation and angiogenesis. A key aspect of GSAO-B was produced as described by Donoghue et al. (2000) and has a this molecule is the glutathione pendant that safely delivers the molecular weight of 1001. A solution of fluorescein-5-EX succinimidyl ester (Molecular Probes, Eugene, Oregon) (2.4 mg, 4.1 mol) in DMSO (240 l) arsenical warhead to endothelial cell mitochondria both in vitro was added to GSAO or GSAA (33.8 mM) in Mes buffer, pH 5.5 (5 mM, 473 and in vivo. The features of this pendant that permit delivery of l), the mixture was diluted with bicarbonate buffer, pH 9 (0.5 M, 3.287 ml) the arsenical are currently being defined and refined. and allowed to stand at room temperature for 80 min. The reaction was then diluted with glycine (100 mM) in phosphate-buffered saline (PBS) (4 ml) and Experimental procedures allowed to stand at room temperature overnight. The final solution contained trivalent arsenical (2 mM) and glycine (50 mM). The molar ratio of fluoresceinSynthesis of GSAA 5X to GSAO or GSAA was ‫.1:5.1ف‬ The molecular weights of GSAO-and BRAA was prepared by a modification of the method described in Donoghue GSAA-fluorescein (GSAO-F and GSAA-F) are 1024 and 1040, respectively. et al. (2000) . p-Arsanilic acid (20.6 g, 95 mmol) was added in portions to a solution of sodium carbonate (20 g, 189 mmol) in water (200 ml). When all Assay of arsenical concentration solids had dissolved, the solution was found to be pH 10 and was chilled
The concentrations of GSAO, GSAO-B, and GSAO-F were measured by at 4ЊC for 2 hr. Bromoacetyl bromide (15 ml, 173 mmol) in dry dichloromethtitrating with dimercaptopropanol and calculating the remaining free thiols ane (35 ml) was added in two portions, each addition followed by vigorous with 5,5Ј-dithiobis(2-nitrobenzoic acid) (Sigma, St. Louis, Missouri) (Donshaking for 2 to 3 min. The mixture was allowed to stand for a few min, and oghue et al., 2000) . The conjugates were sterile filtered and stored at 4ЊC the lower organic layer was drained off. 4-(N-(Bromoacetyl)amino)benzenin the dark until use. There was no significant loss in the active concentration earsonic acid (BRAA) was precipitated by acidification of the solution to of stock solutions of the arsenicals for at least a month when stored under about pH 2-3 with the dropwise addition of 98% sulfuric acid, collected by these conditions. All GSAO and GSAA solutions used for experiments were vacuum filtration and dried, giving BRAA as a white solid. BRAA (3.38 g, 10 dissolved in PBS containing 100 mM glycine. The glycine slows the oxidation mmol), reduced glutathione (3.23 g, 10.5 mmol), and sodium bicarbonate (3.15 g, 37.5 mmol) were mixed together, and the solid mixture was dissolved of GSAO to GSAA (Donoghue et al., 2000) .
Mitochondrial swelling assay
Immunocytochemistry and confocal microscopy Mitochondria were isolated from the livers of ‫052ف‬ g male Wistar rats using BAE cells were seeded at a density of 10 4 cells per well into 8-well Labtek differential centrifugation as described previously (Schnaitman and Greena- glass chamber slides (Nunc, Naperville, Illinois) and allowed to adhere overwalt, 1968). The final mitochondrial pellet was resuspended in 3 mM HEPESnight. The cells were then incubated for 1 hr with 50 M GSAO-F, 50 M KOH, pH 7.0 buffer containing 213 mM mannitol, 71 mM sucrose, and GSAO-F and 250 M dimercaptopropanol, or 50 M GSAA-F. All cells 10 mM sodium succinate at a concentration of 30 mg of protein per ml.
were counterstained with 100 nM MitotrackerTM Red CMXRos (Molecular Mitochondrial permeability transition induction was assessed spectrophotoProbes). The cells were then washed three times with serum-free medium metrically by suspending the liver mitochondria at 0.5 mg of protein per ml and fixed for 10 min with 80% acetone and 20% methanol. Slides were at 25ЊC in 3 mM HEPES-KOH, pH 7.0 buffer containing 75 mM mannitol, mounted in VectaShield antifade agent (Vector Laboratories, Burlingame, 250 mM sucrose, 10 mM sodium succinate, and 2 M rotenone. Swelling California) and sealed with nail polish. Images were captured using a Leica was measured by monitoring the associated decrease in light scattering at DM IRB inverted microscope and confocal system, with Leica confocal 520 nm using a Molecular Devices Thermomax Plus (Palo Alto, California) software. microplate reader. All reagents were purchased from Sigma.
Cellular uptake assay Detection of mitochondrial proteins that bind GSAO
GSAO or GSAA was synthesized using tritiated glutathione (Amersham BioRat liver mitochondria were suspended at 1 mg protein per ml in 3 mM sciences, Buckinghamshire, United Kingdom). HMEC-1 cells were seeded HEPES-KOH, pH 7.0 buffer containing 213 mM mannitol, 71 mM sucrose, at a density of 5 ϫ 10 5 cells per well in 6-well culture plates and allowed to and 10 mM sodium succinate and incubated with 10 M GSAO-B or GSAA-B attach overnight. Cells were incubated with 3 M tritiated GSAO or GSAA for 1 hr at room temperature on a rotating wheel. The mitochondria were in the presence of 100 M unlabeled reduced glutathione. The medium was washed once with buffer, then sonicated in 0.3 ml ice-cold 25 mM Tris, pH removed and the cells were washed twice with PBS, detached with 20 mM 7.4 buffer containing 140 mM NaCl, 2.7 mM KCl, 0.5% Triton X-100, 0.05% EDTA/PBS, washed once with PBS, and solubilized with 100 l of 20 mM Tween-20, 3 M Urea, 10 M leupeptin, 1 M aprotinin, 50 g.ml Ϫ1 4-2-Tris, pH 7.4 buffer containing 0.14 M NaCl, 1% Triton X-100, 0.5% sodium (aminoethyl)-benzene sulfonyl fluoride and 5 mM EDTA. Lysate was clarified deoxycholate, 0.1% SDS, 2 mM EGTA, 50 g·ml Ϫ1 AEBSF, 10 g·ml Ϫ1 by centrifugation at 18000 g for 10 min at 4ЊC and incubated with 30 l of leupeptin, 1.0 M aprotinin, and 1 g·ml Ϫ1 pepstatin A. Samples were mixed streptavidin-dynabeads (Dynal, Oslo, Norway) for 2 hr at 4ЊC to isolate the with 5 ml aqueous scintillant ACSII (Amersham Pharmacia, Uppsala, Swebiotin-labeled proteins. The beads were washed twice with sonication buffer den) and counted for 4 min. Results were the mean Ϯ standard error of and twice with 25 mM Tris buffer containing 140 mM NaCl and 0.5% Triton triplicate cell treatments. X-100. Proteins bound specifically to GSAO's arsenical moiety were eluted from the beads by incubation with 40 l of 25 mM Tris buffer containing 50 Cellular Ca 2؉ assay mM dithiothreitol for 5 min (Donoghue et al., 2000) . The eluted proteins were BAE cells were seeded at 10 5 cells per well into 12-well plates in medium resolved on 8%-16% gradient iGels (Gradipore, Sydney, Australia) under containing 10% serum, allowed to adhere overnight, then cultured for 24 or reducing conditions and silver stained.
48 hr in medium containing 10% or 0.25% serum. The cells were washed with PBS, incubated for 30 min in PBS containing 0.2% BSA and 2.5 M Binding of GSAO to ANT Indo-1 (Sigma), washed once, then incubated for 60 min in medium conRat liver mitochondria were prepared as described above and incubated taining 0.25% or 10% serum. The cells were detached with trypsin/EDTA, with 10 M GSAO-B in the absence or presence of 50 M 2,3-dimercaptowashed once to remove trypsin, resuspended in growth medium, and transpropanol (Fluka, Buchs, SG, Switzerland). The GSAO-B labeled proteins ferred to ice. Fluorescence was measured immediately using excitation at were collected as described above, resolved on 8%-16% gradient iGels 350 nm and 510/20 nm (Ca 2ϩ bound) and 440/40 nm (Ca 2ϩ -free) emission under reducing conditions, and transferred to PVDF membrane. Proteins filters. The ratio of violet/blue fluorescence was used to determine the relative were detected by Western blot using a 1:500 dilution of goat anti-human intracellular Ca 2ϩ concentration. ANT polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, California) and 1:2000 dilution of rabbit anti-goat peroxidase-conjugated antibodies Cell proliferation and viability assays (Dako, Carpinteria, California) .
To assay cell number with methylene blue, BAE cells were seeded at a density of 10 4 cells per well into 96-well plates and allowed to adhere overLabeling of ANT with eosin-5-maleimide night. Cells were arrested for 24 hr in medium containing 0.25% serum and Rat liver submitochondrial particles were prepared by sonication and differcultured for a further 48 hr in medium containing 0.25% or 10% serum, in ential centrifugation according to Majima et al. (1998) . The particles were the presence of GSAO or PAO. Attached cells remaining after treatments suspended at 20 mg of protein per ml in 10 mM Tris, pH 7.2 buffer containing were measured using methylene blue (Oliver et al., 1989) . The anti-prolifera-250 mM sucrose and 0.2 mM EDTA and incubated without or with 200 nmol tive and cytotoxic effects of GSAO were assayed by flow cytometry with GSAO per mg of protein for 10 min at 25ЊC, followed by 20 nmol of eosinpropidium iodide. Endothelial and tumor cells were seeded at a density of 5-maleimide per mg of protein for 1 min at 0ЊC in the dark. The labeling was 5 ϫ 10 4 cells per well into 12-well plates, allowed to adhere overnight, then terminated by addition of 10 mmol of dithiothreitol per mg of protein. The treated for 48 hr with GSAO. Adherent cells were detached with trypsin/ proteins were resolved on 4%-20% gradient iGels and the eosin-labeled EDTA and combined with the growth medium containing the cells that had ANT was visualized by UV transillumination using a Fluor-S MultiImager detached during treatment. The combined cells were pelleted, resuspended (Bio-Rad, Hercules, California). in 0.5 ml serum-free medium containing 1 g·ml Ϫ1 propidium iodide (PI) (Molecular Probes), and analyzed by flow cytometry. The number of viable Cell culture cells in the untreated control was normalized to 100%, and viability for all BAE cells were from Cell Applications, San Diego, California and BxPC-3, GSAO treatments was expressed as a percentage of control. HT1080, LLC, A549, and HL60 cells were from ATCC, Bethesda, Maryland. BAE, HT1080, and LLC cells were cultured in DMEM, BxPC-3 cells in RPMI ATP assay medium, A549 cells in F-12K medium, HL60 cells in IMDM, and HMEC-1 BAE cells in 6-well culture plates were arrested for 24 hr in 0.5% serum or cells (Ades et al., 1992) in MCDB131 medium. The cells were supplemented left in 10% serum, then treated for 24 hr with GSAO. The cells were washed with 10% fetal calf serum (FBS), 2 mM L-glutamine, and 1 U·ml Ϫ1 penicillin/ once then resuspended in 0.4 ml PBS containing 0.2% bovine serum albustreptomycin. HDMVE cells were a gift from Dr. Chris Jackson (Jackson et min. A 50 l sample of cells was mixed with 50 l water and 100 l ATP al., 1990) and cultured in MCDB131 supplemented with 20% human serum, releasing agent and ATP concentration was measured using a luciferin/ 50 g·ml Ϫ1 endothelial cell growth supplement, 50 g·ml Ϫ1 heparin, 10 luciferase ATP assay mix (Sigma). Light units were converted to ATP concenng·ml Ϫ1 epidermal growth factor, and 1 g·ml Ϫ1 hydrocortisone. Cell culture trations using an ATP standard in place of the 50 l water. Cell number was plasticware was from Techno Plastic Products (Trasadingen, Switzerland).
counted using a Beckman Coulter Counter and mol of ATP was expressed Epidermal growth factor, hydrocortisone, and heparin were from Sigma. All other cell culture reagents were from Gibco (Gaithersburg, Maryland).
per million cells.
